Literature DB >> 32537944

Myelin and Lipid Composition of the Corpus Callosum in Mucopolysaccharidosis Type I Mice.

Steven Q Le1,2, Igor Nestrasil3, Shih-Hsin Kan1,4, Martin Egeland1, Jonathan D Cooper1,2, David Elashoff5, Rong Guo5, Jakub Tolar3,6, Jennifer K Yee1, Patricia I Dickson1,2.   

Abstract

Mucopolysaccharidosis type I (MPS I) is a lysosomal disease with progressive central nervous system involvement. This study examined the lipid, cholesterol, and myelin basic protein composition of white matter in the corpus callosum of MPS I mice. We studied 50 week-old, male MPS I mice and littermate, heterozygote controls (n = 12 per group). Male MPS I mice showed lower phosphatidylcholine and ether-linked phosphatidylcholine quantities than controls (p < 0.05). Twenty-two phospholipid or ceramide species showed significant differences in percent of total. Regarding specific lipid species, MPS I mice exhibited lower quantities of sphingomyelin 18:1, phosphatidylserine 38:3, and hexosylceramide d18:1(22:1) mH2 O than controls. Principal components analyses of polar, ceramide, and hexosylceramide lipids, respectively, showed some separation of MPS I and control mice. We found no significant differences in myelin gene expression, myelin basic protein, or total cholesterol in the MPS I mice versus heterozygous controls. There was a trend toward lower proteolipid protein-1 levels in MPS I mice (p = 0.06). MPS I mice show subtle changes in white matter composition, with an unknown impact on pathogenesis in this model.
© 2020 AOCS.

Entities:  

Keywords:  Glycosaminoglycans; Hurler syndrome; Inborn errors of metabolism; Lipidomics; Lysosomal storage disease

Year:  2020        PMID: 32537944      PMCID: PMC7992919          DOI: 10.1002/lipd.12261

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  34 in total

1.  Neurochemistry of the mucopolysaccharidoses: brain lipids and lysosomal enzymes in patients with four types of mucopolysaccharidosis and in normal controls.

Authors:  G Constantopoulos; A S Dekaban
Journal:  J Neurochem       Date:  1978-05       Impact factor: 5.372

2.  Bone marrow transplantation for Hurler syndrome: assessment of metabolic correction.

Authors:  C B Whitley; N K Ramsay; J H Kersey; W Krivit
Journal:  Birth Defects Orig Artic Ser       Date:  1986

Review 3.  Phosphatidylserine in the brain: metabolism and function.

Authors:  Hee-Yong Kim; Bill X Huang; Arthur A Spector
Journal:  Prog Lipid Res       Date:  2014-06-30       Impact factor: 16.195

4.  A comprehensive study of the postnatal changes in the concentration of the lipids of developing rat brain.

Authors:  M A Wells; J C Dittmer
Journal:  Biochemistry       Date:  1967-10       Impact factor: 3.162

5.  Subregional brain distribution of simple and complex glycosphingolipids in the mucopolysaccharidosis type I (Hurler syndrome) mouse: impact of diet.

Authors:  Jennifer T Saville; Hong Ngoc Thai; Rebecca J Lehmann; Ainslie L K Derrick-Roberts; Maria Fuller
Journal:  J Neurochem       Date:  2017-03-13       Impact factor: 5.372

6.  Quantitative profiling of polar glycerolipid species from organs of wild-type Arabidopsis and a phospholipase Dalpha1 knockout mutant.

Authors:  Shivakumar Pattada Devaiah; Mary R Roth; Ethan Baughman; Maoyin Li; Pamela Tamura; Richard Jeannotte; Ruth Welti; Xuemin Wang
Journal:  Phytochemistry       Date:  2006-07-14       Impact factor: 4.072

7.  Lipidomic analysis of Toxoplasma gondii reveals unusual polar lipids.

Authors:  Ruth Welti; Ernie Mui; Alexis Sparks; Sarah Wernimont; Giorgis Isaac; Michael Kirisits; Mary Roth; Craig W Roberts; Cyrille Botté; Eric Maréchal; Rima McLeod
Journal:  Biochemistry       Date:  2007-11-08       Impact factor: 3.162

8.  Features of brain MRI in dogs with treated and untreated mucopolysaccharidosis type I.

Authors:  Charles H Vite; Igor Nestrasil; Anton Mlikotic; Jackie K Jens; Elizabeth M Snella; William Gross; Elsa G Shapiro; Victor Kovac; James M Provenzale; Steven Chen; Steven Q Le; Shih-hsin Kan; Shida Banakar; Raymond Y Wang; Mark E Haskins; N Matthew Ellinwood; Patricia I Dickson
Journal:  Comp Med       Date:  2013-04       Impact factor: 0.982

9.  Murine mucopolysaccharidosis type I: targeted disruption of the murine alpha-L-iduronidase gene.

Authors:  L A Clarke; C S Russell; S Pownall; C L Warrington; A Borowski; J E Dimmick; J Toone; F R Jirik
Journal:  Hum Mol Genet       Date:  1997-04       Impact factor: 6.150

10.  Substrate Deprivation Therapy to Reduce Glycosaminoglycan Synthesis Improves Aspects of Neurological and Skeletal Pathology in MPS I Mice.

Authors:  Ainslie L K Derrick-Roberts; Matilda R Jackson; Carmen E Pyragius; Sharon Byers
Journal:  Diseases       Date:  2017-02-23
View more
  1 in total

1.  Quantitative brain MRI morphology in severe and attenuated forms of mucopolysaccharidosis type I.

Authors:  Victor Kovac; Elsa G Shapiro; Kyle D Rudser; Bryon A Mueller; Julie B Eisengart; Kathleen A Delaney; Alia Ahmed; Kelly E King; Brianna D Yund; Morton J Cowan; Julian Raiman; Eva G Mamak; Paul R Harmatz; Suma P Shankar; Nadia Ali; Stephanie R Cagle; Jeffrey R Wozniak; Kelvin O Lim; Paul J Orchard; Chester B Whitley; Igor Nestrasil
Journal:  Mol Genet Metab       Date:  2022-01-07       Impact factor: 4.797

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.